je.st
news
Axovant Sciences - The Late Clinical Stage Biotech With Huge IPO Potential
2015-06-09 21:00:38| Biotech - Topix.net
Axovant Sciences is a late-stage clinical trial biotech preparing for its initial public offering the week of June 8. The company's lead drug candidate is an Alzheimer's treatment currently in Phase 3 trials. Axovant acquired the intellectual property and rights from GlaxoSmithKline .
Tags: potential
late
stage
huge
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||